<H1>Chapter DOI: 10.1007/s11419-006-0016-0<br/>Cited-By Count: 7</H1><table border="1" width="30%"><tr><td>Total References</td><td>19</td></tr><tr><td>Springer references</td><td>2</td></tr><tr><td>Non Springer references</td><td>17</td></tr><tr><td>BibStructured Count</td><td width="10%">19</td></tr><tr><td>BibUnstructured Count</td><td width="10%">0</td></tr><tr><td>DOI already available in SpringerLink</td><td>7</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>6</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>6</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>6</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr><tr><td>Valid DOI Enriched</td><td>4</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>Christensen HD, Freudenthal RI, Gidley JT, Rosenfeld R, Boegli G, Testino L, Brine DR, Pitt CG, Wall ME (1971) Activity of &#948;<Superscript>8</Superscript>-and &#948;<Superscript>9</Superscript>-tetrahydrocannabiol and related compounds in the mouse. Science 172:165&#8211;167</td><td><a href=http://dx.doi.org/10.1126/science.172.3979.165>10.1126/science.172.3979.165</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Perez-Reyes M, Timmons MC, Davis KH, Wall ME (1973) A comparison of the pharmacological activity in man of intravenously administered &#948;<Superscript>9</Superscript>-tetrahydrocannabinol, cannabinol, and cannabidiol. Experientia 29:1368&#8211;1369</td><td><a href=http://dx.doi.org/10.1007/BF01922823>10.1007/BF01922823</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Watanabe K, Yamaki E, Yamamoto I, Yoshimura H (1979) A colorimetric method for the determination of cannabinoids with Fast Bule BB salt. Eisei Kagaku 25:321&#8211;326</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Widman M, Nilsson IM, Nilsson JLG, Agurell S, Leander K (1971) Metabolism of cannabis. IX. Cannabinol: structure of a major metabolite formed in rat liver. Life Sci 10:157&#8211;162</td><td><a href=http://dx.doi.org/10.1016/0024-3205(71)90029-4>10.1016/0024-3205(71)90029-4</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Widman M, Dahmen J, Leander K, Petersson K (1975) In vitro metabolism of cannabinol in rat and rabbit liver. Acta Pharm Suec 12:385&#8211;392</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Yisak Y, Widman M, Lindgren J-E, Agurell S (1977) Neutral in vivo metabolites of cannabinol isolated from rat faeces. J Pharm Pharmacol 29:487&#8211;490</td><td><a href=http://dx.doi.org/10.1111/j.2042-7158.1977.tb11374.x>10.1111/j.2042-7158.1977.tb11374.x</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>FirstPage, Author_FamilyName_1, ArticleTitle, Year, VolumeID</td><td>CrossRef</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Harvey DJ, Martin BR, Paton WDM (1980) Identification of in vivo liver metabolites of &#948;<Superscript>1</Superscript>-tetrahydrocannabinol, cannabidiol, and cannabinol produced by the guinea pig. J Pharm Pharmacol 32:267&#8211;271</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1111/j.2042-7158.1980.tb12910.x>10.1111/j.2042-7158.1980.tb12910.x</a></td><td><b>CrossRef-Meta</b></td>
<td>VolumeID, Year, Author_FamilyName_2, Author_FamilyName_1, FirstPage</td><td>CrossRef</td></tr><tr><td>CR8</td><td>BibChapter</td><td>Yamamoto I, Kuzuoka K, Watanabe K, Narimatsu S, Yoshimura H (1988) sMetabolic formation and pharmacological effects of 11-hydroxycannabinol, an active metabolite of cannabinol. In: Chesher G, Consroe P, Musty R (eds) Marihuana: an international research report. National Campaign Against Drug Abuse, monograph series No. 7. Australian Government Printing Office, Canberra, pp 135&#8211;140</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Brown NK, Harvey DJ (1990) In vitro metabolism of cannabinol in rat, mouse, rabbit, guinea pig, hamster, gerbil and cat. Eur J Drug Metabol Pharmacokinet 15:253&#8211;258</td><td><a href=http://dx.doi.org/10.1007/BF03190212>10.1007/BF03190212</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Watanabe K, Matsunaga T, Yamamoto I, Yoshimura H (1995) Involvement of CYP2C in the metabolism of cannabinoids by human hepatic microsomes from an old woman. Biol Pharm Bull 18:1138&#8211;1141</td><td><a href=http://dx.doi.org/10.1248/bpb.18.1138>10.1248/bpb.18.1138</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Year, VolumeID, Author_FamilyName_2, ArticleTitle, FirstPage, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Aramaki H, Tomiyasu N, Yoshimura H, Tsukamoto H (1968) Forensic chemical study on marihuana. I. A detection method of the principal constituents by thin-layer and gas chromatographies. Chem Pharm Bull 16:822&#8211;826</td><td><a href=http://dx.doi.org/10.1248/cpb.16.822>10.1248/cpb.16.822</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_1, FirstPage, ArticleTitle, Year, VolumeID, Author_FamilyName_2</td><td>CrossRef</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Inayama S, Sawa A, Hosoya E (1974) The oxidation of &#948;<Superscript>1</Superscript>-and &#948;<Superscript>6</Superscript>-tetrahydrocannabinol with selenium dioxide. Chem Pharm Bull 22:1519&#8211;1525</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Ben-Zvi Z, Mechoulam R, Burstein S (1970) Synthesis of &#948;<Superscript>1</Superscript>-and &#948;<Superscript>1(6)</Superscript>-tetrahydrocannabinol metabolites. Tetrahedron Lett 51:4495&#8211;4497</td><td><a href=http://dx.doi.org/10.1016/S0040-4039(01)83959-9>10.1016/S0040-4039(01)83959-9</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14</td><td>BibArticle</td><td>Ohlsson A, Agurell S, Leander K, Dahmen J, Edery H, Porath G, Levy S, Mechoulam R (1979) Synthesis and psychotropic activity of side chain hydroxylated &#948;<Superscript>6</Superscript>-tetrahydrocannabinol metabolite. Acta Pharm Suec 16:21&#8211;33</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Watanabe K, Arai M, Narimatsu S, Yamamoto I, Yoshimura H (1986) Effect of repeated administration of 11-hydroxy-&#948;<Superscript>8</Superscript>-tetrahydrocannabinol, an active metabolite of &#948;<Superscript>8</Superscript>-tetrahydrocannabinol, on the hepatic microsomal drugmetabolizing enzyme system of mice. Biochem Pharmacol 35:1861&#8211;1865</td><td><a href=http://dx.doi.org/10.1016/0006-2952(86)90219-4>10.1016/0006-2952(86)90219-4</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Watanabe K, Yamamoto I, Oguri K, Yoshimura H (1980) Identification and determination of 11-oxo-&#948;<Superscript>8</Superscript>-tetrahydrocannabinol as an intermediate metabolite of &#948;<Superscript>8</Superscript>-tetrahydrocannabinol in the mouse brain and liver. J Pharm Dyn 3:686&#8211;691</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1248/bpb1978.3.686>10.1248/bpb1978.3.686</a></td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_2, Year, VolumeID, FirstPage, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265&#8211;275</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Jerina DM, Daly JW (1974) Arene oxide: a new aspect in drug metabolism. Science 185:573&#8211;582</td><td><a href=http://dx.doi.org/10.1126/science.185.4151.573>10.1126/science.185.4151.573</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Yamamoto I, Watanabe K, Kuzuoka K, Narimatsu S, Yoshimura H (1987) The pharmacological activity of cannabinol and its major metabolite, 11-hydroxycannabinol. Chem Pharm Bull 35:2144&#8211;2147</td><td><a href=http://dx.doi.org/10.1248/cpb.35.2144>10.1248/cpb.35.2144</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>ArticleTitle, FirstPage, Author_FamilyName_1, Author_FamilyName_2, Year, VolumeID</td><td>CrossRef</td></tr></table>